Patients with VAP in RICU Patients
Conditions
Brief summary
-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired: community-acquired pneumonia (CAP), when a patient is in the hospital \<48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital \>48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for \>48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.
Detailed description
-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired: community-acquired pneumonia (CAP), when a patient is in the hospital \<48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital \>48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for \>48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patient 18 yrs or more Mechanically ventilated patients after 48 hrs after admission of ICU
Exclusion criteria
* Patient less than 18 yrs Patients diagnosed as pneumonia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients | 4 years | Diagnosis of VAP in RICU Patients |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients | 4 years | Diagnosis of VAP in RICU PATIENTS |